Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies.
about
Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesotheliomaRatio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma.Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity.Changing pattern in malignant mesothelioma survivalSurgical cytoreduction restores the antitumor efficacy of a Listeria monocytogenes vaccine in malignant pleural mesothelioma.Intrapleural Adenoviral-mediated Endothelial Cell Protein C Receptor Gene Transfer Suppresses the Progression of Malignant Pleural Mesothelioma in a Mouse Model.Diagnosis and management options in malignant pleural effusions.Immunotherapy for malignant pleural mesothelioma. Current status and future prospects.Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma.Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cells.Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma.SIRT1 at the crossroads of AKT1 and ERβ in malignant pleural mesothelioma cells.Biphasic Malignant Pleural Mesothelioma Masquerading as a Primary Skeletal Tumor."Lower door open thoracotomy": a feasible approach for extra-pleural pneumonectomy.The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cellsDoes selective pleural irradiation of malignant pleural mesothelioma allow radiation dose escalation? : A planning study.Optimal gross tumor volume definition in lung-sparing intensity modulated radiotherapy for pleural mesothelioma: an in silico study.Comparative proteomic analysis of malignant pleural mesothelioma: Focusing on the biphasic subtype.
P2860
Q33555260-60B68DFA-FE9E-4622-8930-4918E3FB5342Q34142500-6691C2F8-53CA-40A9-8441-74DA268D6879Q34340354-B3273D11-81CD-4AB0-B38F-604B9558560CQ35150628-81DD5C72-5DF0-43E4-B5D5-5D821E66ECB5Q35768107-0C7BEDF3-C37F-4BD4-8CB7-E950EF79B877Q37408325-49B85238-D05C-4947-8A80-20D4DD114943Q37701196-33C0399F-1924-4149-88C7-81404769026FQ38180749-EF7CE261-4FC6-4338-B00C-98AEDA9023A8Q38778106-9991DD78-A117-4F6A-80A3-2DD9EA8A38E3Q38849618-1FAF605D-2A91-45CD-B0BC-AA0CFD37AA85Q39415827-4BDEFCC3-4E33-4E65-ACA4-DC9316C09CD6Q39991261-39F31861-BB34-430D-B4AA-C7538A4AAEA7Q41082952-07EF62E2-44EE-455A-9A1F-40FF2B2AE2C5Q41862688-7397FB4F-1D9C-40DD-96D4-341593C9FE1EQ42038363-3DC7A4F8-D1B7-4D6A-8726-29D832EBE6BFQ47974790-2F6F823B-ABCC-4C60-AC5A-609F1D16223FQ50484415-6E1A3E74-AEA4-4012-99A6-B7108F932E92Q55265819-3E572D49-E77F-48C9-89CF-20B7627DD746
P2860
Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Malignant pleural mesothelioma ...... th a focus on novel therapies.
@ast
Malignant pleural mesothelioma ...... th a focus on novel therapies.
@en
type
label
Malignant pleural mesothelioma ...... th a focus on novel therapies.
@ast
Malignant pleural mesothelioma ...... th a focus on novel therapies.
@en
prefLabel
Malignant pleural mesothelioma ...... th a focus on novel therapies.
@ast
Malignant pleural mesothelioma ...... th a focus on novel therapies.
@en
P2860
P1476
Malignant pleural mesothelioma ...... ith a focus on novel therapies
@en
P2093
Andrew R Haas
P2860
P304
P356
10.1016/J.CCM.2012.12.005
P577
2013-01-17T00:00:00Z